Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Safety, Quality, and Compliance Regulatory status: BPC-157 is not FDA-approved for therapeutic use in humans
The primary concerns with nasal peptides involve nasal irritation if formulations arent pH-optimized, potential mucosal damage from preservatives, and variable absorption due to nasal congestion
Much information indicates that oxidative stress and prostate cancer can be modulated by dietary components rich in antioxidants
Unlike growth hormone releasing peptides that must be taken on an empty stomach, GHK-Cu can be administered regardless of food intake
These users report appreciating treatment benefits while active but watching improvements gradually fade over months post-discontinuation, with timeline showing first 2 months maintaining most benefits creating initial optimism, months 2-4 showing noticeable decline returning toward baseline, months 4-8 continuing regression approaching pre-treatment status, and stabilization occurring 60-80% back toward original baseline with only modest long-term improvement retention
)
